GeneDx Holdings Corp Share Price Today: Live Updates & Key Insights

GeneDx Holdings Corp share price today is $76.85, up -9.69%. The stock opened at $82.64 against the previous close of $85.1, with an intraday high of $83 and low of $75.66.

GeneDx Holdings Corp Share Price Chart

GeneDx Holdings Corp

us-stock
To Invest in {{usstockname}}
us-stock

GeneDx Holdings Corp Share Price Performance

$76.85 -0.0969(-9.69%) WGS at 13 Mar 2026 03:53 PM Diagnostics & Research
Lowest Today 75.66
Highest Today 83
Today’s Open 82.64
Prev. Close 85.1
52 Week High 170.87
52 Week Low 55.17
Day’s Range: Low 75.66 High 83
52-Week Range: Low 55.17 High 170.87
1 day return -
1 Week return -13.52
1 month return -15.33
3 month return -49.37
6 month return -37.49
1 year return -14.81
3 year return +539.95
5 year return -87.1
10 year return -

GeneDx Holdings Corp Institutional Holdings

GeneDx Holdings Corp Market Status

Strong Buy: 5

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

GeneDx Holdings Corp Fundamentals

Market Cap 2492.47 M

PB Ratio 8.0877

PE Ratio 0.0

Enterprise Value 2434.36 M

Total Assets 570.19 M

Volume 931963

GeneDx Holdings Corp Company Financials

Annual Revenue FY25:427539000 427.5M, FY24:305450000 305.5M, FY23:206498000 206.5M, FY22:234694000 234.7M, FY21:212195000 212.2M

Annual Profit FY25:298173000 298.2M, FY24:194397000 194.4M, FY23:42926000 42.9M, FY22:-26750000 -26.8M, FY21:-16602000 -16.6M

Annual Net worth FY25:-21021000 -21.0M, FY24:-52286000 -52.3M, FY23:-458755000 -458.8M, FY22:-548980000 -549.0M, FY21:-245390000 -245.4M

Quarterly Revenue Q4/2025:120989000 121.0M, Q3/2025:116743000 116.7M, Q2/2025:102692000 102.7M, Q1/2025:87115000 87.1M, Q4/2024:95640000 95.6M

Quarterly Profit Q4/2025:78923000 78.9M, Q3/2025:84527000 84.5M, Q2/2025:70902000 70.9M, Q1/2025:58476000 58.5M, Q4/2024:66205000 66.2M

Quarterly Net worth Q4/2025:-17666000 -17.7M, Q3/2025:-7635000 -7.6M, Q2/2025:10809000 10.8M, Q1/2025:-6529000 -6.5M, Q4/2024:5438000 5.4M

About GeneDx Holdings Corp & investment objective

Company Information GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Organisation Diagnostics & Research

Employees 1300

Industry Diagnostics & Research

CEO Ms. Katherine A. Stueland

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right